Evaluation of the revision rates in the treatment of chronic tube dysfunction (ETD)

Background There has been a change in treatment options over the past decade in the treatment of tubal dysfunction. Tubal dilatation is described as a better treatment option in the first prospective randomized trials compared to paracentesis and tympanic tube insertion. Tube augmentation with VOX implants or micro-transferred fat was a new therapeutic option in the treatment of tuba aperta. The aim of this study is the revision rate of o.g. Therapy modalities to check Material and

Methods: The data of 1,547 patients treated in our department for the treatment of chronic tube dysfunction (ETD) via tube dilatation or tube augmentation were evaluated according to the present pathology from 01/2015 to 06/2019. The revision rates of both patient groups were analyzed.

Results: A total of 236 out of 1,547 (15.5 %) patients underwent surgical revision. Re-augmentation was performed in 28 patients (1.8 %, 2 times in 20 patients, 3 times in 4 patients and 4 times in 4 patients) and in re-dilation in 208 patients (13.5 %, 2 times) in 186 patients, 3 in 17 patients and 4 in 4 patients and 5 in one patient).

Conclusion: Data from 1,547 patients showed that both treatment options of chronic tube dysfunction (ETD) via tube dilatation or tube augmentation have recurrences. For the entire patient population of the study period, both therapies demonstrated the need for multiple therapeutic interventions to achieve therapeutic success.

Poster-PDF A-1966.PDF

Publikationsverlauf

Artikel online veröffentlicht:
10. Juni 2020